Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Determining the right percentage of income to save or invest is crucial for financial security. Get guidance to plan effectively.
15,843 articlesA single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Nebius stock skyrocketed more, driven by demand for AI infrastructure. This guide breaks down the drivers, the number...
Broadcom heads into a pivotal Q2 earnings report, with AI demand and data-center growth fueling momentum. This guide ...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As Zepp Health nears the release of its Q1 2026 earnings, investors want clarity on growth, margins, and strategic be...
Bitcoin steadies near $64k as hawkish Fed rhetoric rattles markets. This guide breaks down what to watch, where a flo...
Insider sales spark questions about a stock's health. Here's a practical, data-backed guide to interpret a VP selling...
Analysts push higher targets for AMD as data center AI demand accelerates. A stock price prediction: strong consensus...
ASML’s price sits near the $1,800 mark, sparking questions about a possible stock split. This guide explains what a s...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
June inflation cooled, sparking a rally in crypto markets. Ethereum led the way with a double‑digit gain, while Bitco...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...